XML 139 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Equity
 6 Months Ended
Jun. 30, 2021
Stockholders' Equity Note [Abstract]  
Equity Equity
Share-based compensation
During the six months ended June 30, 2021, the Company granted stock options to purchase 0.3 million shares of common stock and 0.5 million restricted and performance stock units under the Emergent BioSolutions Inc. Stock Incentive Plan. Typically, the stock option and restricted stock unit grants vest over three equal annual installments beginning on the day prior to the anniversary of the grant date. The performance stock units settle in stock at the end of the three-year performance period based on the Company's results compared to the performance criteria.
Share-based compensation expense was recorded in the following financial statement line items:
Three Months Ended June 30,Six Months Ended June 30,
2021202020212020
Cost of product sales and contract development and manufacturing services$2.0 $8.1 $3.7 $8.8 
Research and development1.7 5.4 3.1 6.3 
Selling, general and administrative7.7 10.9 15.1 15.9 
Total share-based compensation expense$11.4 $24.4 $21.9 $31.0 
Accumulated other comprehensive income (loss)
The following table includes changes in accumulated other comprehensive (loss) income by component, net of tax:
(In Millions)
Defined Benefit Pension Plan
Derivative InstrumentsForeign Currency Translation LossesTotal
Balance, December 31, 2020
(7.7)(11.0)(6.6)(25.3)
Other comprehensive (loss) income before reclassifications— 1.6 (1.7)(0.1)
Amounts reclassified from accumulated other comprehensive income— 3.0 — 3.0 
Balance, June 30, 2021
$(7.7)$(6.4)$(8.3)$(22.4)
Balance, March 31, 2021
(7.7)(7.9)(8.8)(24.4)
Other comprehensive (loss) income before reclassifications— (0.1)0.5 0.4 
Amounts reclassified from accumulated other comprehensive income— 1.6 — 1.6 
Balance, June 30, 2021
$(7.7)$(6.4)$(8.3)$(22.4)
Balance, December 31, 2019
(3.4)(1.6)(4.9)(9.9)
Other comprehensive (loss) income before reclassifications— (10.8)(0.4)(11.2)
Amounts reclassified from accumulated other comprehensive income— (1.1)— (1.1)
Balance, June 30, 2020
$(3.4)$(13.5)$(5.3)$(22.2)
Balance, March 31, 2020
(3.4)(12.8)(5.0)(21.2)
Other comprehensive (loss) income before reclassifications— 0.4 (0.3)0.1 
Amounts reclassified from accumulated other comprehensive income— (1.1)— (1.1)
Balance, June 30, 2020
$(3.4)$(13.5)$(5.3)$(22.2)
During the three and six months ended June 30, 2021, the tax impact related to unrealized gains (losses) on hedging activities was an expense of $0.3 million and $1.0 million, respectively; the tax effects of the defined benefit pension plan and foreign currency translation losses were de minimis. During the three and six ended June 30, 2020 there were tax benefits related to unrealized losses on hedging activities of $0.8 million and $3.6 million, respectively; the tax effects of the defined benefit pension plan and foreign currency translation losses were de minimis.